Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis

Trial Profile

Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Jan 2017

At a glance

  • Drugs Ezetimibe (Primary)
  • Indications Non-alcoholic steatohepatitis
  • Focus Therapeutic Use
  • Acronyms MOZART
  • Most Recent Events

    • 24 Jan 2017 Results of a secondary analysis assessing relationship between MRI-derived proton-density fat-fraction (PDFF), total liver volume (TLV), total liver fat index (TLFI) vs. histology published in the Alimentary Pharmacology and Therapeutics
    • 12 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top